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A vasorelaxant whey hydrolysate at semi-pilot scale was generated, assessing the inﬂuence between two
different enzyme inactivation conditions (pH and temperature) and drying technologies (freeze- and
spray-drying). Hydrolysis was performed with 1.25% (w/v) whey protein concentrate solution and 1.91%
(w/w) pepsin (pH 2, 3 h, 37 C). Reactions were stopped either by increasing the pH to 7 (5 M NaOH) or by
heating the solution at 80 C for 5 min. Thermally inactivated samples induced a vascular relaxation
ex vivo above 70%, while the chemically inactivated ones reached only 20%. Both drying technologies
were effective in maintaining the bioactivity of the hydrolysate. These results brought the possibility of
developing a whey-based product with high vasorelaxant potential in semi-pilot scale; thermal treat-
ment followed by spray drying seemed to be the more affordable alternative for food and nutraceutical
industries to generate this bioactive product.
© 2019 Elsevier Ltd. All rights reserved.1. Introduction
The use of whey proteins and whey peptides in sports nutrition,
bakery and infant formulae is well consolidated (Allied Market
Research, 2017). Despite its diversiﬁed use, large part of the whey
produced remains under-utilised, representing a serious environ-
mental concern, because of its high chemical and biochemical de-
mands of oxygen (Dereli, van der Zee, Ozturk,& van Lier, 2019). This
factor, together with the need to create new market niches and
value old products, makes industries seek for new alternatives to
their residues (Yadav et al., 2015).
Among other functionalities, whey proteins and whey peptides
are associated with modulation of hypertension (Beltran-
Barrientos, Hernandez-Mendoza, Torres-Llanez, Gonzalez-
Cordova, & Vallejo-Cordoba, 2016; O'Keeffe, Conesa, & FitzGerald,
2017), a chronic disease with high prevalence, which its compli-
cations account for 9.4 million deaths every year (WHO, 2015).
Despite the lack of molecular studies, it is generally described that
whey peptides may induce vascular relaxation and putatively
reduce the blood pressure through differentmechanisms, including. Mellinger-Silva).inhibition of the angiotensin converting enzyme (ACE) and renin,
stimulation of nitric oxide production, and blockage of calcium
channels, among others (Udenigwe & Mohan, 2014). Besides all
well-known health beneﬁts, there are only a few commercial
products available on the market based on the antihypertensive
activity of whey peptides (Beltran-Barrientos et al., 2016), high-
lighting the need of more studies in this ﬁeld.
The main challenge of food and nutraceutical industries consists
of high costs of production of the antihypertensive peptides since
different advanced technologies are required. Therefore, the pre-
sent study aimed at producing a whey protein hydrolysate with
vasorelaxant effect by the use of commercial pepsin in a semi-pilot
scale, assessing the inﬂuence of two different enzyme inactivation
conditions and drying technologies.
2. Materials and methods
2.1. Materials
Bovine whey protein concentrate (WPC), containing 88% protein,
2% carbohydrate, 1.6% lipid and 8.4% cholesterol, vitamins and min-
erals, was provided by Alibra Ingredientes Ltda (Campinas, SP, Brazil).
Porcine pepsin (enzyme activity: 0.28 mUmL1) was provided by Bela
L. Ozorio et al. / International Dairy Journal 93 (2019) 11e1412Vista Produtos Enzimaticos Ind. e Com. Ltda (Bela Vista, SC, Brazil).
Phenylephrine hydrochloride, acetylcholine chloride, and all salt used
to prepare the physiological saline solution (PSS) were purchased
from Sigma-Aldrich (St. Louis, MO, USA). All other reagents were of
analytical grade.
2.2. Whey hydrolysate preparation
Hydrolyses were performed according to Mellinger-Silva et al.
(2015). Brieﬂy, in a semi-pilot scale reactor of 20 L, WPC was sus-
pended in distilled water at a concentration of 1.25% (w/v) and the
pH was adjusted to 2 with 1 M HCl. Pepsin (4.2 g) was used to pre-
pare 1.05 L of enzyme solution (0.4%, w/v), corresponding to 1.91 g of
pepsin per gram of protein (1.91%, w/w). Pepsin solutionwas further
added to the WPC solution and the reaction occurred during 3 h at
37 C. Temperature and pH were monitored during all the process.
Pepsin was either thermally (80 C for 5 min) (TI) or chemically
inactivated (CI) by increasing pH up to 7 with 5 M NaOH. Samples
were either freeze-dried at 52 C, 67.73 Pa (Liotop, S~ao Paulo,
Brazil) or spray-dried at 0.52 MPa (inlet temperature: 170 C; outlet
temperature: 85 C) (Buchi Labortechnik, Flawil, Switzerland).
2.3. Reversed-phase high performance liquid chromatography
Reversed-phase high performance liquid chromatography (RP-
HPLC) was performed according to Mellinger-Silva et al. (2015). A
HPLC (Jasco, S~ao Paulo, Brazil) coupled with a BDS Hypersil C18
(100  4.6 mm, particle size 2.4 mm, Thermo Scientiﬁc, USA) was
used. Triﬂuoracetic acid (TFA) in ultrapure water (0.1%, v/v) and
0.1% TFA in acetonitrile (v/v) were used as solvents A and B,
respectively. Hydrolysates were eluted as follows: 0e2 min, 5% B;
2e15 min, 5e20% B; 15e20 min, 20e30% B; 20e25 min, 30e40%
B; 25e28 min, 40e50% B; 28e32 min, 50e60% B; 32e34 min,
60e70% B; 34e36 min, 70e80% B; 36e38 min, 80e5% B;
38e40 min, 5% B. Runs occurred at a ﬂow rate of 1.0 mL min1 for
40 min at ambient temperature (approximately 20 C). The
detection wavelength used was 216 nm. Bovine a-lactalbumin (a-
La) and b-lactoglobulin (b-Lg) from bovine milk (Sigma-Aldrich)
were used as standards with retention times of 29.84 and
30.70 min, respectively.Fig. 1. Flow diagram of a proposed industrial pla2.4. Aortic ring preparation and analyses of vascular relaxation
Six male Wistar rats (250e300 g) provided by Universidade Fed-
eral de Santa Catarina (Florianopolis, Brazil) were used in the exper-
iments, which were approved by our local Institutional Animal Care
and Use Committee (authorisation number 5371190815). Animals
were maintained under standard laboratory conditions at controlled
temperature (22 ± 2 C)with free access towater and diet ad libitum.
For these experiments, animals were killed by anaesthetic overdose
(ketamine and xylazine,140 and 40mg kg1, i.p.) and the preparation
of endothelium-intact rat aortic rings was performed as previously
described (Mellinger-Silva et al., 2015). Brieﬂy, the aortic rings were
mounted in organ baths and kept in PSS [composition (in mM): NaCl,
131.3; KCl, 4.7; KH2PO4, 1.18; MgSO47H2O, 1.17; NaHCO3, 14.9; D-
glucose, 5.5; CaCl22H2O, 1.6; EDTA, 0.08], pH 7.4, at 37 C and
continuously bubbledwith95%O2/5%CO2. Toevaluate thepresenceof
a functional endothelium, acetylcholine (1 mmol L1) was used to
induce relaxation in phenylephrine (1 mmol L1)-contracted prepara-
tions. Only the rings that achieved 80% relaxation to acetylcholine
were considered with functional endothelium.
The changes in vascular tone were recorded by isometric force
transducers, coupled to a recording system PowerLab® and its
application software LabChart v7.4 (both from ADInstruments,
Castle Hill, Australia). After stabilisation, the vessels were contracted
by 1 mmol L1 phenylephrine and cumulative concentrations of the
hydrolysed fractions (1, 3, 5 and 10 mg mL1) were added.
The results were expressed as the mean ± SEM of 6 aortic rings
from different animals per group. Each preparation was tested with
only one of the hydrolysed fractions. The resultswere analysed using
two-way analysis of variance (ANOVA) followed by Tukey's post hoc
analysis. A value of p < 0.05 was considered statistically signiﬁcant.
Graphs and statistical analyses were performed using GraphPad
Prismversion 7 forWindows (GraphPad Software, La Jolla, CA, USA).
3. Results and discussion
Process scale up is essential when aiming to develop an ingre-
dient for food industries; processes changes must be well
controlled to avoid alterations in the ﬁnal product. The integrative
process for the development of whey-based products with highnt for whey protein hydrolysate production.
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natura whey, membrane concentration, hydrolysis, drying and
packing (Fig. 1) (O'Keeffe et al., 2017; Tavares et al., 2012).
Enzymes are extensively used to generate biofunctional prod-
ucts (Le Maux, Nongonierma, Barre, & Fitzgerald, 2016). Pepsin
presents high afﬁnity for cleaving peptide bonds between hydro-
phobic and preferably aromatic amino acids (Bannigan et al., 2018).
The presence of these amino acid residues at each of the C-terminal
tripeptide positions seems to be related to the angiotensin I-con-
verting enzyme (ACE) inhibition, which may be considered a good
physiological target for the clinical treatment of hypertension, as it
is involved in the control of blood pressure through two different
systems, the renin-angiotensin and the kinin-nitric oxide systems
(Ko et al., 2015; Norris & Fitzgerald, 2013). Pepsin is also found inFig. 2. Peptide proﬁles of whey hydrolysates assessing different enzyme inactivation
conditions and drying technologies: (A) control sample, whey protein concentrate 88%;
a-La: a-lactalbumin; b-Lg: b-lactoglobulin; CI (adjusted to pH 7) lyophilised (B) and
spray-dried (C) samples; TI (80 C  5 min) lyophilised (D) and spray-dried (E)
samples.
Fig. 3. Vascular relaxation induced by whey hydrolysates in rat aortic rings pre-
contracted by phenylephrine. Panel A: percentage relaxation as a function of cumu-
lative concentrations of 1, 3, 5, 10 mg mL1 of the whey hydrolysates CI (adjusted pH to
7; , ) and TI (80 C  5 min; , ) lyophilised (circles) or spray-dried (squares) were
added; * indicates signiﬁcant vascular relaxation (p < 0.005) for both TI samples, #
indicates p < 0.005 compared with the previous concentration of used in TI samples
(two-way ANOVA followed by Tukey's post hoc test. The results were expressed as the
mean ± SEM of 6 aortic rings from different animals per group. Panels B and C, patterns
of change in vascular tone contracted by phenylephrine followed by addition of (B) CI
spray-dried hydrolysate and (C) TI spray-dried hydrolysate.
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peptic hydrolysis of the WPC, any in vivo gastric digestion is ex-
pected further, possibly allowing a controlled formation of the
vasorelaxant peptides. More studies are being carried out to eval-
uate the inﬂuence of the gastrointestinal digestion in the release of
the bioactive peptides.
Besides the choice of the enzyme, its inactivation and the
method used to dry the solution are also parameters that may in-
ﬂuence the composition of the hydrolysate and its bioactivity.
Among the drying methods, lyophilisation is well-known for pre-
serving quality and the integrity of bioactive compounds in food
matrices; however, it requires high energy and presents opera-
tional costs about six-times higher than spray-drying (Haque &
Adhikari, 2015; Schulze, Hubbermann, & Schwarz, 2014). The
spray-dryer, more commonly used in the food industries, applies
high working temperatures, possibly causing heat degradation and
affecting the stability of thermally labile compounds (Drosou,
Krokida, & Biliaderis, 2016).
Fig. 2B and C reveals that the drying method may inﬂuence the
peptide formation of the CI samples, as the freeze-dried hydroly-
sate presented a more varied peptide composition than the spray-
dried one. This may be related to the heat and pressure applied
during spray-drying, causing sample degradation with generation
of free amino acids (Drosou et al., 2016). The samewas not observed
for the TI samples, as both lyophilized (Fig. 2D) and spray-dried
(Fig. 2E) samples presented similar peptide proﬁles, including hy-
drophobic and hydrophilic molecules. Comparing CI and TI sam-
ples, it is possible to observe higher b-Lg hydrolysis in the TI ones
than in the CI samples, which may be a result of the thermal
denaturation of this protein during the thermal inactivation pro-
cess (Fig. 2).
As shown in Fig. 3, the enzyme inactivation method directly
inﬂuenced the biofunctionality of the hydrolysates, as TI samples
were able to induce greater vasorelaxant effect when compared
with CI samples (Fig. 3A). Notably, CI spray-dried hydrolysate
completely lacked capability to induce vascular relaxation,
compared with TI sample (Fig. 3B and C). Furthermore, the TI hy-
drolysate induced signiﬁcant levels of vascular relaxation in pre-
contracted aortic rings, achieving 72.1 ± 11.4% and 81.0 ± 14.3%,
for the freeze- and spray-dried samples, respectively.
4. Conclusions
The present study revealed that enzyme inactivation was an
important step in the process of generation of a whey hydrolysate
with vasorelaxant activity. The heat inactivated hydrolysates pre-
sented higher vascular relaxant potential than those that were
chemically inactivated. Despite applying high temperatures and
pressure, the spray-drying technology presented a tendency to be
more efﬁcient in maintaining vascular relaxation capacity of the
hydrolysate, besides presenting lower working costs and reduced
process time compared with freeze-drying, being a more feasible
technology to food industries. In this manner, thermal inactivation
of pepsin followed by spray-drying the hydrolysate might be rec-
ommended for the generation of an antihypertensive whey hy-
drolysate in semi-pilot scale.Acknowledgements
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